Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Nov 12 - Nov 17
Direct-to-patient access removes the insurance middleman, allowing individuals to invest in proven prevention at a fraction of downstream medical costs
GLP-1 is a hormone released from the gut after meals that: Stimulates insulin release when blood sugar is high Reduces glucagon levels Slows stomach emptying Signals satiety to the brain Modern GLP-1based medications (semaglutide alone and tirzepatide as a dual GIP/GLP-1 agonist) mimic or combine these effects
Apr 28th, 2026 How Retatrutide Impacts Weight Loss and Metabolism Retatrutide is an investigational triple agonist targeting GIP, GLP-1, and glucagon receptors that has shown significant weight loss and metabolic benefits in trials, but it is not yet FDA-approved and remains available only in clinical studies
Functions: - Antioxidant protection: neutralizes free radicals, protecting cells from oxidative stress
For female fertility, 1,000-3,000 mg per day is generally recommended
